<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02614924</url>
  </required_header>
  <id_info>
    <org_study_id>RD098211</org_study_id>
    <nct_id>NCT02614924</nct_id>
  </id_info>
  <brief_title>Comparison of Flexible Fibreoptic Scope With Pentax AWS Videolaryngoscope for Ease of Intubation During Awake Intubation</brief_title>
  <official_title>Comparison of Flexible Fibreoptic Scope With Pentax AWS Videolaryngoscope for Ease of Intubation During Awake Intubation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospitals Coventry and Warwickshire NHS Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospitals Coventry and Warwickshire NHS Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to identify whether Pentax Airway Scope (AWS) videolaryngoscope
      would be a more effective device compared to flexible fibreoptic scope (FOS) for awake
      intubation in a difficult airway.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background:

      The incidence of difficult tracheal intubation during routine anaesthesia in general
      population is around 3-18% although it varies [1]. Awake intubation is considered in
      situations such as in patients with a known or suspected difficult airway, upper airway
      obstruction. Awake intubation under local anaesthesia and sedation also indicated cervical
      spine disease in view of minimising movement of cervical spine [2]. Any technique tracheal
      intubation under general anaesthesia involves some degree of movement at cervical spine.
      Direct laryngoscopy and tracheal intubation in under general anaesthesia is usually achieved
      by flexion of lower cervical spine and extension at atlanto-occipital joint [3]. Difficulties
      or failure in airway management is still an important factor in morbidity and mortality
      related to anaesthesia.

      In recent years videolaryngoscopes have been used as an alternative to traditional fibreoptic
      scope in the management of difficult airway [4,7,8]. Over last 2 years in our institution the
      investigators have used Pentax AWS videolaryngoscope for awake intubation in patients
      presenting for surgery with cervical spine disease [9, 10].

      However there has not been any study comparing flexible fibreoptic scope with video
      laryngoscopes in the management of difficult airway in awake patients. The proposed benefits
      of Pentax AWS (Airway scope) over a flexible fibreoptic scope include ease of setting up the
      device, less complexity of the skill, therefore easy to learn the skill and availability of
      disposable devices minimising the need for cleaning and disinfecting the device.

      Pentax AWS with PBlade videolaryngoscope has a unique target symbol displayed on the monitor,
      which highlights the intended path of the endotracheal tube. The Pentax PBlade is a single
      patient use device that minimizes the risk of infection.

      Study Design and Methods: Randomised Controlled Trial

      Patient Selection:

      Forty patients presenting for cervical spine surgery under general anaesthesia and requiring
      oral endotracheal intubation will be invited to take part in the study. During preoperative
      visit, a patient information sheet will be given to the patients meeting the eligible
      criteria. The patient will be given adequate time to read the information sheet and any
      queries will be answered. Wherever possible, suitable patients will be identified in the
      preoperative assessment clinic. A detailed airway assessment will be performed by one of the
      investigator.

      Whenever possible, when patients are admitted the night before their operation, they should
      be seen by an Anaesthetist and given the study information.

      Techniques of Anaesthesia:

      After securing intravenous cannulation and instituting standard anaesthetic monitoring with
      ECG, pulse oximetry and non-invasive blood pressure monitoring, conscious sedation will be
      started using target controlled infusion of remifentanil and 1 mg of midazolam. At this stage
      numbered opaque envelope will be opened to choose one of the two devices. The tongue,
      oropharynx and larynx will be anaesthetised using 4% lignocaine using Mckenzie technique
      (nebulisation of local anaesthetic through 20 G cannula).

      Adequate anaesthesia of upper airway will be checked by inserting an appropriately sized
      oropharyngeal airway (if the patient can tolerate well, the airway is anesthetised
      adequately, if not further local anaesthetic is administered to the oropharynx). After
      confirming adequate anaesthesia of upper airway, the chosen device will be inserted into the
      oropharynx. Further local anaesthesia to the base of the tongue, larynx and trachea will be
      administered using spray as you go technique where the local anaesthetic administered through
      the device whilst gradually advancing the device towards larynx. After confirming the
      position of the tracheal tube and testing the gross neurological state of all 4 limbs,
      general anaesthesia will be induced.

      Data Collection:

      During the procedure of laryngoscopy and endotracheal intubation, a modified intubation
      difficulty score (IDS) would be developed based on the parameter recorded. Along with
      intubation difficulty score other parameters compared include: time taken to complete the
      process of intubation, anaesthetist rating of intubation and patient rating of procedure.

      The following parameter would be recorded and scored:

        1. Coughing episode: 0 no cough 1 if mild cough, 2 if moderate cough, 3 if severe cough.

        2. Gagging episode: 0 no gagging, 1 if mild gag, 2 if moderate gag, 3 if severe gag.

        3. Ease of insertion of device: 0 easy, 1 if mild difficulty 2 if moderately difficulty, 3
           very difficult.

        4. Laryngoscope view based on the percentage of the glottis visualised 0 if 75-100% view, 1
           if 50-75% view, 2 if &lt;50% view, 3 no VC visible.

        5. Tube rotation or manipulation, 0 if no rotation required, 1 if rotation required

        6. Airway trauma, 0 no trauma, 1 if minor injury (lip), 2 if oro-pharyngeal injury/
           bleeding. 3, bleeding requiring use of suction

        7. Stress response based on heart rate and blood pressure (0 if stable, 1 if increased more
           than 20%)

        8. Overall patients' tolerance as judged by the Anaesthetists (visual analogue score of 0
           to 100mm)

        9. Overall impression from patient on a visual analogue scale (visual analogue score of 0
           to 100mm)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total Time Taken to Complete the Procedure of Awake Intubation</measure>
    <time_frame>up to 20 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intubation Time</measure>
    <time_frame>up to 10 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Anesthesia Intubation Complication</condition>
  <arm_group>
    <arm_group_label>Flexible fibre-optic scope</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Randomly allocated to fibreoptic group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pentax AWS videolaryngoscope</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Randomly allocated Pentax AWS videolaryngoscope</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Flexible fibreoptic scope</intervention_name>
    <description>Patient intubated using fibreoptic scope</description>
    <arm_group_label>Flexible fibre-optic scope</arm_group_label>
    <arm_group_label>Pentax AWS videolaryngoscope</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pentax AWS videolaryngoscope</intervention_name>
    <description>Patient intubated using Pentax AWS videolaryngoscope</description>
    <arm_group_label>Flexible fibre-optic scope</arm_group_label>
    <arm_group_label>Pentax AWS videolaryngoscope</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with cervical spine disease presenting for cervical spinal surgery and
             requiring awake intubation under local anaesthesia and conscious sedation.

          -  Patients with anticipated difficult airway include those with Mallampati class 3 and
             above, other signs such as limited neck movement and limited jaw protrusion will be
             include in the study

        Exclusion Criteria:

          -  Children below 18 years of age, pregnant mothers and patients presenting with airway
             pathology will be excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 24, 2015</study_first_submitted>
  <study_first_submitted_qc>November 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2015</study_first_posted>
  <results_first_submitted>March 16, 2016</results_first_submitted>
  <results_first_submitted_qc>July 12, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 22, 2016</results_first_posted>
  <last_update_submitted>July 12, 2016</last_update_submitted>
  <last_update_submitted_qc>July 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients were recruited between 27.11.12 till 24.7.14. Recruitment was done during anaesthetic prep assessment.</recruitment_details>
      <pre_assignment_details>No participants were excluded</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Flexible Fibre-optic Scope</title>
          <description>Randomly allocated to fibreoptic group
Flexible fibreoptic scope: Patient intubated using fibreoptic scope</description>
        </group>
        <group group_id="P2">
          <title>Pentax AWS Videolaryngoscope</title>
          <description>Randomly allocated to Pentax AWS</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Flexible Fibre-optic Scope</title>
          <description>Randomly allocated to fibreoptic group
Flexible fibreoptic scope: Patient intubated using fibreoptic scope</description>
        </group>
        <group group_id="B2">
          <title>Pentax AWS Videolaryngoscope Group</title>
          <description>Randomly allocated Pentax AWS videolaryngoscope and intubated using Pentax AWS videolaryngoscope</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="40"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55.5" lower_limit="23" upper_limit="77"/>
                    <measurement group_id="B2" value="66.5" lower_limit="44" upper_limit="77"/>
                    <measurement group_id="B3" value="60.5" lower_limit="23" upper_limit="77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Total Time Taken to Complete the Procedure of Awake Intubation</title>
        <time_frame>up to 20 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Flexible Fibre-optic Scope</title>
            <description>Randomly allocated to fibreoptic group
Flexible fibreoptic scope: Patient intubated using fibreoptic scope</description>
          </group>
          <group group_id="O2">
            <title>Pentax AWS Videolaryngoscope</title>
            <description>randomly allocated to Pentax AWs</description>
          </group>
        </group_list>
        <measure>
          <title>Total Time Taken to Complete the Procedure of Awake Intubation</title>
          <units>seconds</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="900" lower_limit="739" upper_limit="1059"/>
                    <measurement group_id="O2" value="651" lower_limit="601" upper_limit="720"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intubation Time</title>
        <time_frame>up to 10 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Flexible Fibre-optic Scope</title>
            <description>Randomly allocated to fibreoptic group
Flexible fibreoptic scope: Patient intubated using fibreoptic scope</description>
          </group>
          <group group_id="O2">
            <title>Pentax AWS Videolaryngoscope</title>
            <description>Randomly allocated to Pentax AWS</description>
          </group>
        </group_list>
        <measure>
          <title>Intubation Time</title>
          <units>seconds</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="420" lower_limit="283" upper_limit="480"/>
                    <measurement group_id="O2" value="183" lower_limit="144" upper_limit="220"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>20 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Flexible Fibre-optic Scope</title>
          <description>Randomly allocated to fibreoptic group
Flexible fibreoptic scope: Patient intubated using fibreoptic scope</description>
        </group>
        <group group_id="E2">
          <title>Pentax AWS Videolaryngoscope</title>
          <description>Randomly allocated to Pentax AWS group Pentax AWS videolaryngoscope group: Patient intubated with Pentax AWS</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Ratidzo Danha</name_or_title>
      <organization>UHCW NHS Trust</organization>
      <phone>02476 964000 ext 25871</phone>
      <email>Ratidzo.Danha@uhcw.nhs.uk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

